GW25-e1716 Effect of Atorvastatin on Endothelial Function and Rho Kinase Activity in Patients with Stable Coronary Heart Disease  by Lianna, Xie
HR¼1.919, 95% CI 1.009-3.650, P¼0.047) and non-responders (18.3%, HR¼2.119,
95% CI 1.045-4.292, P¼0.037) when grouping by the platelet function phenotype,
without a statistical difference of the major adverse cardiovascular events rate or
cardiovascular symptom events rate.
Conclusions: Genotyping of CYP2C19 is a better predictor of cardiovascular
symptom events, while phenotyping of platelet response to clopidogrel is a better
predictor of bleeding events in CHD patients received coronary stent implantation.
Further study design and clinical practice should take it into account in both anti-
platelet therapy strategy decision and long term prognosis prediction.
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Objectives: In addition to inhibiting cholesterol synthesis, statins decrease the for-
mation of isoprenoid intermediates required for the activation of RhoARho kinase
pathway. Increased Rho kinase activity has been implicated in endothelial dysfunction
and plays pivotal roles in cardiovascular diseases including coronary heart disease
(CHD). The present study was undertaken to investigate whether higher dose of statin
can quickly inhibit Rho kinase activity and reverse vascular dysfunction in CHD
patients.
Methods: 20 consecutive stable CHD patients were treated with 80 mg atorvastatin.
At baseline and 12 hours late after treatment, the ﬂow-mediated vasodilation (FMD)
was assessed by 2-dimensional ultrasonography of the brachial artery and the leu-
cocyte Rho kinase activity was assessed by Western Blot.
Results: Treatment with atorvastatin 80 mg increased FMD by 16.95%
(5.401.65% vs 7.842.96%, P<0.05) and reduced Rho kinase activity by 20.28%
(43.43.5% vs 34.66.9%, P<0.05). There was a modest correlation between
reduction in Rho kinase activity and improvement in ﬂow-mediated dilation
(r¼0.58, P<0.05).
Conclusions: High-dose atorvastatin can rapidly improve vascular endothelium
dysfunction in stable CHD patients. The inhibiting of the RhoA/Rho-kinase pathway
may involve in the beneﬁt of statins in improving endothelium dysfunction.
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Objectives: To investigate the expression level of human plasma Platelet-activating
factor (PAF) in different types of coronary heart disease and the correlation between
PAF and coronary Gesini Score.
Methods: 140 subjects with suspected CHD were divided into groups including 32
normal healthy control subjects and 108 patients with CHD which was further divided
into subgroups including 30 patients with acute myocardial infarction (AMI), 41
unstable angina pectoris (UAP), 37 stable angina pectoris (SAP). The plasma PAF
concentrations were determined by ELASA and the degree of coronary stenosis was
illustrated by Gesini Score, and then the concentrations were compared between the
groups and the relationship between the concentrations and Gesini Score was
analyzed.
Results: Plasma concentrations of PAF were higher in patients with CHD
(12.262.02) ng/ml than those in normal healthy control group (6.271.35) ng/ml
(P<0. 01), and higher in AMI group (13.311.36) ng/ml and UAP group
(13.011.48) ng/ml than in SAP group (10.611.97) ng/ml (P<0. 01). Strong pos-
itive correlations existed between the plasma PAF concentrations and Gesini Score
(r¼0.642, P <0.01), and differences are statistically signiﬁcant.
Conclusions: Human Plasma PAF concentrations were various in different types of
coronary heart disease and were correlated with coronary Gesini Score, which sug-
gests that PAF may serve as an available index for CHD.
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Objectives: Without doubt the immediate angiographic results of coronary occlusion
are dramatic. The occluded artery becomes patent almost instantaneously after balloon
dilatation. However, the long-term outcomes remain in dispute. It is especially true
when the comparison was made between successful and failed percutaneous coronary
intervention (PCI). To reduce the major difference unrelated to occlusion theC120 JACC Vol 64/16/Suppl C j October 16–1comparison is made between occlusion and stenosis. To minimize selection bias a
propensity score is used.
Methods: From 2008 to 2009 4431 patients underwent coronary angiography (CAG).
After exclusion of multiple CAG 253 patients with occlusion and 629 with stenosis
were included. To reduce selection bias propensity score was used, which resulted in
253 patients in each group. The patients were then managed with PCI, coronary artery
bypass grafting (CABG) or medication, and followed from 1 month to 5 years. The
primary end point was the major adverse cardiac events (MACE), including
myocardial infarction (MI), heart failure (HF), stroke and death.
Results: Before propensity score matching signiﬁcant differences were observed
between occlusion and stenosis in clinical characteristics. After propensity score
matching the differences disappeared except for the Syntax score. However, the
propensity score matching did not change the MACE. Among the MACE only
mortality showed signiﬁcant difference between occlusion and stenosis (11% vs 4%,
P<0.05), and the PCI resulted in increased mortality in occlusion compared with
stenosis (12% vs 2%, P<0.05). The cumulated survival curve showed reduced
survival in patients with occlusion, P<0.05. Compared among 3 strategies there were
no signiﬁcant differences, P¼0.05. However, CABG had a trend of increased
mortality.
Conclusions: Occlusion of coronary artery carries poor long-term prognosis. The PCI
to the occlusion resulted in higher mortality in comparison with PCI of stenosis. In
general, mortality is higher in CABG although the P value was only equal to 0.05.
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Objectives: Sufﬁcient coronary collateral circulation (CCC) network limits infarct
size, preserves myocardial function and improves the prognosis. The discovery of
biomarkers for detection of CCC will help to anticipate the prognosis and facilitate the
new strategies of enhancing collateral formation. The aim of this study was to observe
the relationship between plasma microRNA126 (miR-126) level and coronary
collateral circulation (CCC) formation and to explore whether the miR-126 in plasma
could serve as a blood-based biomarker for CCC in patients with severely narrowed
coronary arteries.
Methods: 120 CAD patients in Beijing Anzhen hospital who had equal to or greater
than 95% stenosis in one epicardial coronary artery were enrolled consecutively. They
were divided into two groups according to Rentrop grades: patients with grade 2 and 3
collateral development were regarded as good CCC group (n¼64) and patients with
grade 0-1 collateral development were regarded as poor CCC group (n¼56). Plasma
miR-126 was measured by RT-PCR and serum VEGF was evaluated by ELISA
method. The data were statistically analyzed by Pearson and Logistic correlation
analysis. The diagnosis value of plasma miR-126 was evaluated Receiver Operating
Characteristic (ROC) analysis.
Results: There was no statistically signiﬁcant difference for basal demographic and
clinical features between the two groups, except fasting plasma glucose (FPG). Pa-
tients with good CCC had a lower FPG than patients with poor CCC ( (5.991.48)
mmol/L vs (6.402.50) mmol/L). Patients with good CCC had higher miR-126 and
VEGF levels compared with poor CCC (0.060.02 vs 0.030.01, P¼0.021,
(2549.30614.12) ng/L vs (1758.61451.67) ng/L, P¼0.008)). In CAD patients with
good CCC, the miR-126 level was correlated to the VEGF expression (OR¼2.145,
95% CI 1.691 - 2.988, P¼0.001). In multivariate analysis, plasma miR-126 was an
independent predictor of collateral development. In CAD patients, the area under the
miR-126 curve is 0.714 (P¼0.005).
Conclusions: Plasma miR-126 level was closely related to the CCC formation and
was an independent predictor of CCC development, which suggests that plasma miR-
126 may be a new, stable blood biomarker of predicting CCC.
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Objectives: Coronary artery disease (CAD) is one of the main causes of chronic
mortality in China. Chest pain is the most frequent symptom of CAD. The aim of this
study was to provide a qualitative and quantitative coronary angiographic analysis of
Chinese men and women with suspected ischemic chest pain and identify clinical
predictors of signiﬁcant CAD.9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
